Optimizing Fluid Management Guided by Volumetric Parameters in Patients with Sepsis and ARDS

Int J Mol Sci. 2023 May 15;24(10):8768. doi: 10.3390/ijms24108768.

Abstract

We compared two de-escalation strategies guided by either extravascular lung water or global end-diastolic volume-oriented algorithms in patients with sepsis and ARDS. Sixty patients with sepsis and ARDS were randomized to receive de-escalation fluid therapy, guided either by the extravascular lung water index (EVLWI, n = 30) or the global end-diastolic volume index (GEDVI, n = 30). In cases of GEDVI > 650 mL/m2 or EVLWI > 10 mL/kg, diuretics and/or controlled ultrafiltration were administered to achieve the cumulative 48-h fluid balance in the range of 0 to -3000 mL. During 48 h of goal-directed de-escalation therapy, we observed a decrease in the SOFA score (p < 0.05). Extravascular lung water decreased only in the EVLWI-oriented group (p < 0.001). In parallel, PaO2/FiO2 increased by 30% in the EVLWI group and by 15% in the GEDVI group (p < 0.05). The patients with direct ARDS demonstrated better responses to dehydration therapy concerning arterial oxygenation and lung fluid balance. In sepsis-induced ARDS, both fluid management strategies, based either on GEDVI or EVLWI, improved arterial oxygenation and attenuated organ dysfunction. The de-escalation therapy was more efficient for direct ARDS.

Keywords: acute respiratory distress syndrome; de-escalation therapy; extravascular lung water; global end-diastolic volume; hemodynamics; sepsis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Extravascular Lung Water
  • Fluid Therapy
  • Humans
  • Lung
  • Respiratory Distress Syndrome* / therapy
  • Sepsis* / complications
  • Sepsis* / therapy

Grants and funding

This research received no external funding.